|
GlaxoSmithKline Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
52624.29 Cr.
|
P/BV
|
21.01
|
Book Value (Rs.)
|
147.85
|
|
52 Week High/Low (Rs.)
|
3121/2088
|
FV/ML
|
10/1
|
P/E(X)
|
50.80
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
61.15
|
Div Yield (%)
|
1.83
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 2826.37 | 2774.84 | 2523.91 | 2464.27 | 2468.40 |
| Total Income From Operations | 2826.37 | 2774.84 | 2523.91 | 2464.27 | 2468.40 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 323.09 | 384.67 | 340.57 | 333.38 | 463.08 |
| Purchase of Traded Goods | 682.05 | 553.71 | 597.34 | 610.64 | 545.34 |
| Increase/Decrease in Stocks | 1.92 | 100.54 | 29.49 | -3.94 | -3.59 |
| Employees Cost | 442.50 | 426.73 | 451.56 | 446.15 | 470.19 |
| Depreciation | 53.27 | 52.07 | 51.58 | 48.59 | 52.84 |
| Other Expenses | 418.54 | 465.02 | 453.52 | 443.49 | 406.72 |
| Total Expenses | 1921.37 | 1982.74 | 1924.06 | 1878.31 | 1934.58 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 905.00 | 792.10 | 599.85 | 585.96 | 533.82 |
| Other Income | 109.41 | 105.25 | 92.76 | 73.00 | 57.02 |
| P/L Before Interest, Excpt. Items & Tax | 1014.41 | 897.35 | 692.61 | 658.96 | 590.84 |
| Interest | 2.12 | 0.73 | 1.03 | 1.16 | 1.72 |
| P/L Before Exceptional Items & Tax | 1012.29 | 896.62 | 691.58 | 657.80 | 589.12 |
| Exceptional Items | 20.62 | 4.69 | -146.01 | -11.37 | -17.92 |
| P/L Before Tax | 1032.91 | 901.31 | 545.57 | 646.43 | 571.20 |
| Tax | 274.79 | 236.60 | 150.09 | 172.22 | 135.77 |
| P/L After Tax from Ordinary Activities | 758.12 | 664.71 | 395.48 | 474.21 | 435.43 |
| Extra Ordinary Item | 0.00 | 0.00 | 0.00 | 3.05 | 40.24 |
| Net Profit/Loss For the Period | 758.12 | 664.71 | 395.48 | 477.26 | 475.67 |
| Net P/L After Minority Interest & Share Of Associates | 758.12 | 664.71 | 395.48 | 477.26 | 475.67 |
| | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 44.75 | 39.24 | 29.77 | 28.17 | 28.08 |
| Diluted EPS (Rs.) | 44.75 | 39.24 | 23.35 | 28.17 | 28.08 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 44.75 | 39.24 | 29.77 | 28.17 | 28.08 |
| Diluted EPS (Rs.) | 44.75 | 39.24 | 23.35 | 28.17 | 28.08 |
| | | | | | |
| PBITOE Margin (%) | 32.01 | 28.54 | 23.76 | 23.77 | 21.62 |
| PBTE Margin (%) | 35.81 | 32.31 | 27.40 | 26.69 | 23.86 |
| PBT Margin (%) | 36.54 | 32.48 | 21.61 | 26.23 | 23.14 |
| PAT Margin (%) | 26.82 | 23.95 | 15.66 | 19.36 | 19.27 |
| PAT After MI And SOA Margin (%) | 26.82 | 23.95 | 15.66 | 19.36 | 19.27 |
